Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AT42
Term | Name | Level | Count |
---|---|---|---|
GO:0002097 | tRNA wobble base modification | 7 | 12 |
GO:0002098 | tRNA wobble uridine modification | 8 | 12 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 12 |
GO:0006400 | tRNA modification | 6 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009451 | RNA modification | 5 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0034470 | ncRNA processing | 7 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008173 | RNA methyltransferase activity | 4 | 12 |
GO:0008175 | tRNA methyltransferase activity | 5 | 12 |
GO:0016300 | tRNA (uracil) methyltransferase activity | 6 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:0000049 | tRNA binding | 5 | 1 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 270 | 274 | PF00656 | 0.519 |
CLV_NRD_NRD_1 | 171 | 173 | PF00675 | 0.445 |
CLV_NRD_NRD_1 | 232 | 234 | PF00675 | 0.338 |
CLV_PCSK_FUR_1 | 169 | 173 | PF00082 | 0.432 |
CLV_PCSK_FUR_1 | 229 | 233 | PF00082 | 0.448 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.436 |
CLV_PCSK_KEX2_1 | 176 | 178 | PF00082 | 0.400 |
CLV_PCSK_KEX2_1 | 231 | 233 | PF00082 | 0.336 |
CLV_PCSK_PC1ET2_1 | 176 | 178 | PF00082 | 0.417 |
CLV_PCSK_PC7_1 | 172 | 178 | PF00082 | 0.370 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.448 |
CLV_PCSK_SKI1_1 | 237 | 241 | PF00082 | 0.278 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.451 |
CLV_Separin_Metazoa | 150 | 154 | PF03568 | 0.421 |
CLV_Separin_Metazoa | 193 | 197 | PF03568 | 0.422 |
CLV_Separin_Metazoa | 238 | 242 | PF03568 | 0.278 |
DEG_APCC_DBOX_1 | 236 | 244 | PF00400 | 0.237 |
DEG_SPOP_SBC_1 | 108 | 112 | PF00917 | 0.662 |
DOC_CKS1_1 | 185 | 190 | PF01111 | 0.401 |
DOC_MAPK_gen_1 | 229 | 236 | PF00069 | 0.388 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.645 |
DOC_USP7_MATH_1 | 208 | 212 | PF00917 | 0.349 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.531 |
DOC_WW_Pin1_4 | 126 | 131 | PF00397 | 0.507 |
DOC_WW_Pin1_4 | 184 | 189 | PF00397 | 0.401 |
LIG_14-3-3_CanoR_1 | 153 | 160 | PF00244 | 0.450 |
LIG_14-3-3_CanoR_1 | 177 | 185 | PF00244 | 0.318 |
LIG_14-3-3_CanoR_1 | 99 | 105 | PF00244 | 0.566 |
LIG_Actin_WH2_2 | 138 | 155 | PF00022 | 0.336 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.779 |
LIG_BRCT_BRCA1_1 | 210 | 214 | PF00533 | 0.337 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.301 |
LIG_FHA_1 | 314 | 320 | PF00498 | 0.568 |
LIG_FHA_2 | 23 | 29 | PF00498 | 0.593 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.496 |
LIG_LIR_Gen_1 | 330 | 337 | PF02991 | 0.334 |
LIG_LIR_Gen_1 | 50 | 59 | PF02991 | 0.299 |
LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.298 |
LIG_PDZ_Class_3 | 335 | 340 | PF00595 | 0.480 |
LIG_SH2_CRK | 52 | 56 | PF00017 | 0.392 |
LIG_SH2_NCK_1 | 52 | 56 | PF00017 | 0.338 |
LIG_SH2_STAP1 | 147 | 151 | PF00017 | 0.369 |
LIG_SH2_STAP1 | 52 | 56 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.336 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.395 |
LIG_SH2_STAT5 | 93 | 96 | PF00017 | 0.391 |
LIG_SH3_3 | 102 | 108 | PF00018 | 0.587 |
LIG_SH3_3 | 182 | 188 | PF00018 | 0.448 |
LIG_SH3_3 | 28 | 34 | PF00018 | 0.526 |
LIG_SUMO_SIM_anti_2 | 219 | 224 | PF11976 | 0.301 |
LIG_TRAF2_1 | 190 | 193 | PF00917 | 0.370 |
LIG_WRC_WIRS_1 | 132 | 137 | PF05994 | 0.559 |
MOD_CK1_1 | 112 | 118 | PF00069 | 0.680 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.460 |
MOD_CK2_1 | 187 | 193 | PF00069 | 0.308 |
MOD_CK2_1 | 296 | 302 | PF00069 | 0.480 |
MOD_Cter_Amidation | 174 | 177 | PF01082 | 0.370 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.758 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.673 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.461 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.412 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.337 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.441 |
MOD_GlcNHglycan | 70 | 73 | PF01048 | 0.383 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.677 |
MOD_GSK3_1 | 309 | 316 | PF00069 | 0.512 |
MOD_GSK3_1 | 323 | 330 | PF00069 | 0.387 |
MOD_N-GLC_2 | 332 | 334 | PF02516 | 0.320 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.554 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.374 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.410 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.229 |
MOD_PIKK_1 | 152 | 158 | PF00454 | 0.421 |
MOD_PKA_1 | 171 | 177 | PF00069 | 0.442 |
MOD_PKA_2 | 152 | 158 | PF00069 | 0.450 |
MOD_PKA_2 | 171 | 177 | PF00069 | 0.421 |
MOD_PKA_2 | 323 | 329 | PF00069 | 0.381 |
MOD_PKA_2 | 98 | 104 | PF00069 | 0.326 |
MOD_PKB_1 | 169 | 177 | PF00069 | 0.442 |
MOD_Plk_2-3 | 22 | 28 | PF00069 | 0.670 |
MOD_Plk_2-3 | 309 | 315 | PF00069 | 0.565 |
MOD_Plk_4 | 323 | 329 | PF00069 | 0.359 |
MOD_ProDKin_1 | 126 | 132 | PF00069 | 0.509 |
MOD_ProDKin_1 | 184 | 190 | PF00069 | 0.401 |
MOD_SUMO_for_1 | 178 | 181 | PF00179 | 0.370 |
MOD_SUMO_rev_2 | 12 | 17 | PF00179 | 0.601 |
TRG_DiLeu_BaEn_1 | 238 | 243 | PF01217 | 0.306 |
TRG_DiLeu_BaLyEn_6 | 31 | 36 | PF01217 | 0.286 |
TRG_ENDOCYTIC_2 | 294 | 297 | PF00928 | 0.316 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.380 |
TRG_ER_diArg_1 | 169 | 172 | PF00400 | 0.462 |
TRG_ER_diArg_1 | 231 | 233 | PF00400 | 0.336 |
TRG_NLS_MonoExtC_3 | 14 | 20 | PF00514 | 0.717 |
TRG_NLS_MonoExtC_3 | 175 | 181 | PF00514 | 0.409 |
TRG_Pf-PMV_PEXEL_1 | 157 | 161 | PF00026 | 0.358 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3I4 | Leptomonas seymouri | 62% | 100% |
A0A0S4J705 | Bodo saltans | 37% | 100% |
A0A1X0NKG3 | Trypanosomatidae | 45% | 100% |
A0A3S7XB23 | Leishmania donovani | 88% | 100% |
A0A422ND22 | Trypanosoma rangeli | 40% | 100% |
A4HPD1 | Leishmania braziliensis | 78% | 100% |
A4ICH1 | Leishmania infantum | 88% | 100% |
C4V9L5 | Nosema ceranae (strain BRL01) | 30% | 100% |
D0A3J1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
P49957 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 27% | 100% |
Q4Q1F6 | Leishmania major | 89% | 100% |
V5DGL8 | Trypanosoma cruzi | 43% | 100% |